Bank of Nova Scotia’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,795
| Closed | -$932K | – | 1240 |
|
|
2022
Q3 | $932K | Buy |
3,795
+37
| +1% | +$9.09K | ﹤0.01% | 802 |
|
|
2022
Q2 | $930K | Sell |
3,758
-1,873
| -33% | -$464K | ﹤0.01% | 853 |
|
|
2022
Q1 | $1.87M | Sell |
5,631
-3,025
| -35% | -$1M | ﹤0.01% | 821 |
|
|
2021
Q4 | $3.11M | Buy |
8,656
+1,253
| +17% | +$450K | ﹤0.01% | 769 |
|
|
2021
Q3 | $2.41M | Buy |
7,403
+675
| +10% | +$220K | ﹤0.01% | 779 |
|
|
2021
Q2 | $2.1M | Sell |
6,728
-1,684
| -20% | -$526K | ﹤0.01% | 769 |
|
|
2021
Q1 | $2.68M | Buy |
8,412
+830
| +11% | +$265K | 0.01% | 705 |
|
|
2020
Q4 | $2.46M | Buy |
7,582
+1,852
| +32% | +$600K | 0.01% | 630 |
|
|
2020
Q3 | $1.59M | Buy |
+5,730
| New | +$1.59M | ﹤0.01% | 658 |
|
|
2020
Q1 | – | Sell |
-1,226
| Closed | -$209K | – | 969 |
|
|
2019
Q4 | $209K | Hold |
1,226
| – | – | ﹤0.01% | 896 |
|
|
2019
Q3 | $218K | Sell |
1,226
-7,893
| -87% | -$1.4M | ﹤0.01% | 865 |
|
|
2019
Q2 | $2.38M | Buy |
9,119
+543
| +6% | +$141K | 0.01% | 572 |
|
|
2019
Q1 | $2.45M | Sell |
8,576
-45,070
| -84% | -$12.9M | 0.01% | 581 |
|
|
2018
Q4 | $17.4M | Buy |
53,646
+28,506
| +113% | +$9.27M | 0.08% | 199 |
|
|
2018
Q3 | $11.3M | Buy |
25,140
+20,469
| +438% | +$9.2M | 0.05% | 290 |
|
|
2018
Q2 | $1.91M | Buy |
+4,671
| New | +$1.91M | 0.01% | 501 |
|
|
2016
Q3 | – | Sell |
-18,130
| Closed | -$1.98M | – | 734 |
|
|
2016
Q2 | $1.98M | Buy |
+18,130
| New | +$1.98M | 0.01% | 266 |
|